Clinical Trials Directory

Trials / Unknown

UnknownNCT03570866

PET/CT in the Management of Patients With Early Stage Endometrial Cancer

Positron Emission Tomography and Computed Tomography in the Management of Early Stage Intermediate and High-risk Endometrial Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Università degli Studi dell'Insubria · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Endometrial cancer (EC) is the most common gynecologic malignancy in the developed countries and is the fifth most common cancer among women worldwide. Typically present well or moderately differentiated, early stage endometrioid histotype with a prognosis usually favorable. Pelvic lymph nodes (LNs) represent the most common site of extra-uterine disease in patients with clinical early stage disease and the role of lymphadenectomy in early stage EC has been one of the major controversies in gynecology oncology. Lymphadenectomy doesn't improve survival or reduce disease recurrence although supported to provide prognostic information and allowing tailoring of adjuvant therapy. Nevertheless, lymphadenectomy is not performed without serious short-term and long-term morbidity. Although surgical staging is the most accurate and standard method to determine LNs involvement, the introduction in clinical practice of a non-invasive modality that allows an accurate staging of EC would be essential. Available evidence report the accuracy of Positron Emission Tomography and Computed Tomography (PET/CT) for the detection of LN metastasis in EC with a sensitivity of 63% and specificity of 94.7%. This prospective comparative analysis between PET/CT, histological findings, and follow up data will be performed to investigate the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of integrated PET/CT for nodal staging of EC per patient and per LN chain analyses, in women affected by intermediate (grade 1 and 2 endometrioid lesions with deep myometrial invasion \> 50% or grade 3 endometrioid lesion with \< 50% myometrial invasion) or high risk (grade 3 endometrioid lesion with deep myometrial invasion \> 50% or non-endometrioid histotype) early-stage EC. Furthermore, the preoperative classification of EC in intermediate and high-risk class will allow to investigate its prognostic value.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPositron emission tomography and computed tomographyPreoperative staging of early stage intermediate and high-risk endometrial cancer with positron emission tomography and computed tomography.
PROCEDURESurgical treatmentSurgical treatment of early stage intermediate and high-risk endometrial cancer by usual practice: peritoneal cytology, total abdominal hysterectomy, bilateral salpingo-oophorectomy, systematic pelvic and para-aortic lymphadenectomy.

Timeline

Start date
2022-05-01
Primary completion
2023-05-01
Completion
2024-05-01
First posted
2018-06-27
Last updated
2021-09-30

Source: ClinicalTrials.gov record NCT03570866. Inclusion in this directory is not an endorsement.